The H4R antagonist, JNJ-7777120 treatments ameliorate mild traumatic brain injury by reducing oxidative damage, inflammatory and apoptotic responses through blockage of the ERK1/2/NF-κB pathway in a rat model

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8fb8365f2d425c1e-LAX IP: 116.62.10.13 UTC time: 2025-01-02T05:05:09+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4